About Technology Issues FAQ

Links

Official Page

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.